Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01710319 · ClinicalTrials.gov registry record
Mechanisms of Immunosurveillance for Lung Cancer
A clinical trial of Lung Cancer, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 119
- Enrollment target
- 1
- Study location
NCT01710319: Completed study of Lung Cancer, sponsored by Washington University School of Medicine.
NCT01710319 is a study of Lung Cancer that has completed, run by Washington University School of Medicine. The registered enrollment target is 119 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01710319, a study of Lung Cancer, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to investigate the differences in "natural killer (NK) blood cells, a type of white blood cell that fights infection in the body, among different types of patients that have lung surgery. The four different groups of patients are: * smokers with lung cancer * smokers without lung cancer * non-smokers with lung cancer * non-smokers without lung cancer.
Primary Outcome
The first outcome measure is the determination of the number of NK cells as a percentage of all CD45+cells.
Conditions Studied
Interventions
- OTHER blood draw
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2012-09 |
| Est. Completion | 2016-07-07 |
What the finished NCT01710319 record still lists
NCT01710319 is an observational study that tracks outcomes without assigning an intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which blood draw is the first listed.
NCT01710319 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT01710319 about?
NCT01710319 is a clinical study titled "Mechanisms of Immunosurveillance for Lung Cancer". The purpose of this research study is to investigate the differences in "natural killer (NK) blood cells, a type of white blood cell that fights infection in the body, among different types of patients that have lung surgery. The four different groups of patients are: * smokers with lung cancer * s...
What is the current status of trial NCT01710319?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2012-09. Estimated completion is 2016-07-07.
What conditions does trial NCT01710319 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT01710319?
The interventions under investigation include: blood draw (OTHER).
Who is sponsoring clinical trial NCT01710319?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01710319 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01710319's enrollment target sits among peer trials
119 172nd of 409 higher than 236 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia